These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 35730384)

  • 1. Long-lasting adaptive immune memory specific to SARS-CoV-2 in convalescent coronavirus disease 2019 stable people with HIV.
    Donadeu L; Tiraboschi JM; Scévola S; Torija A; Meneghini M; Jouve T; Favà A; Calatayud L; Ardanuy C; Cidraque I; Preyer R; Strecker K; Lozano JJ; Podzamczer D; Crespo E; Bestard O
    AIDS; 2022 Aug; 36(10):1373-1382. PubMed ID: 35730384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Robust Vaccine-Induced as Well as Hybrid B- and T-Cell Immunity across SARS-CoV-2 Vaccine Platforms in People with HIV.
    Verburgh ML; van Pul L; Grobben M; Boyd A; Wit FWNM; van Nuenen AC; van Dort KA; Tejjani K; van Rijswijk J; Bakker M; van der Hoek L; Schim van der Loeff MF; van der Valk M; van Gils MJ; Kootstra NA; Reiss P
    Microbiol Spectr; 2023 Jun; 11(3):e0115523. PubMed ID: 37166335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensive assessment of long-term SARS-CoV-2-specific adaptive immune memory in convalescent COVID-19 Solid Organ Transplant recipients.
    Favà A; Donadeu L; Jouve T; Gonzalez-Costello J; Lladó L; Santana C; Toapanta N; Lopez M; Pernin V; Facundo C; Cabañas NS; Thaunat O; Crespo M; Llinàs-Mallol L; Revuelta I; Sabé N; Rombauts A; Calatayud L; Ardanuy C; Esperalba J; Fernandez C; Lozano JJ; Preyer R; Strecker K; Couceiro C; García-Romero E; Cachero A; Meneghini M; Torija A; Le Quintrec M; Melilli E; Cruzado JM; Polo C; Moreso F; Crespo E; Bestard O
    Kidney Int; 2022 May; 101(5):1027-1038. PubMed ID: 35124011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of Severe Illness After Postvaccination COVID-19 Breakthrough Among Adults With and Without HIV in the US.
    Lang R; Humes E; Coburn SB; Horberg MA; Fathi LF; Watson E; Jefferson CR; Park LS; Gordon KS; Akgün KM; Justice AC; Napravnik S; Edwards JK; Browne LE; Agil DM; Silverberg MJ; Skarbinski J; Leyden WA; Stewart C; Hogan BC; Gebo KA; Marconi VC; Williams CF; Althoff KN;
    JAMA Netw Open; 2022 Oct; 5(10):e2236397. PubMed ID: 36227594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of Postvaccination Breakthrough COVID-19 Infections Among Adults With HIV in the United States.
    Coburn SB; Humes E; Lang R; Stewart C; Hogan BC; Gebo KA; Napravnik S; Edwards JK; Browne LE; Park LS; Justice AC; Gordon KS; Horberg MA; Certa JM; Watson E; Jefferson CR; Silverberg MJ; Skarbinski J; Leyden WA; Williams CF; Althoff KN;
    JAMA Netw Open; 2022 Jun; 5(6):e2215934. PubMed ID: 35671054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Chronic HIV Infection on Acute Immune Responses to SARS-CoV-2.
    Opsteen S; Fram T; Files JK; Levitan EB; Goepfert P; Erdmann N
    J Acquir Immune Defic Syndr; 2024 May; 96(1):92-100. PubMed ID: 38408318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-existing cell populations with cytotoxic activity against SARS-CoV-2 in people with HIV and normal CD4/CD8 ratio previously unexposed to the virus.
    Casado-Fernández G; Cantón J; Nasarre L; Ramos-Martín F; Manzanares M; Sánchez-Menéndez C; Fuertes D; Mateos E; Murciano-Antón MA; Pérez-Olmeda M; Cervero M; Torres M; Rodríguez-Rosado R; Coiras M
    Front Immunol; 2024; 15():1362621. PubMed ID: 38812512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 memory B and T cell profiles in mild COVID-19 convalescent patients.
    Gurevich M; Zilkha-Falb R; Sonis P; Magalashvili D; Menascu S; Flechter S; Dolev M; Mandel M; Achiron A
    Int J Infect Dis; 2022 Feb; 115():208-214. PubMed ID: 34896265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postacute sequelae and adaptive immune responses in people with HIV recovering from SARS-COV-2 infection.
    Peluso MJ; Spinelli MA; Deveau TM; Forman CA; Munter SE; Mathur S; Tang AF; Lu S; Goldberg SA; Arreguin MI; Hoh R; Tai V; Chen JY; Martinez EO; Yee BC; Chenna A; Winslow JW; Petropoulos CJ; Sette A; Weiskopf D; Kumar N; Lynch KL; Hunt PW; Durstenfeld MS; Hsue PY; Kelly JD; Martin JN; Glidden DV; Gandhi M; Deeks SG; Rutishauser RL; Henrich TJ
    AIDS; 2022 Oct; 36(12):F7-F16. PubMed ID: 35866847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Immunodeficiency Virus Status, Tenofovir Exposure, and the Risk of Poor Coronavirus Disease 19 Outcomes: Real-World Analysis From 6 United States Cohorts Before Vaccine Rollout.
    Lea AN; Leyden WA; Sofrygin O; Marafino BJ; Skarbinski J; Napravnik S; Agil D; Augenbraun M; Benning L; Horberg MA; Jefferson C; Marconi VC; Park LS; Gordon KS; Bastarache L; Gangireddy S; Althoff KN; Coburn SB; Gebo KA; Lang R; Williams C; Silverberg MJ
    Clin Infect Dis; 2023 May; 76(10):1727-1734. PubMed ID: 36861341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humoral and cellular immune responses eleven months after the third dose of BNT162b2 an mRNA-based COVID-19 vaccine in people with HIV - a prospective observational cohort study.
    Heftdal LD; Pérez-Alós L; Hasselbalch RB; Hansen CB; Hamm SR; Møller DL; Pries-Heje M; Fogh K; Gerstoft J; Grønbæk K; Ostrowski SR; Frikke-Schmidt R; Sørensen E; Hilsted L; Bundgaard H; Garred P; Iversen K; Sabin C; Nielsen SD
    EBioMedicine; 2023 Jul; 93():104661. PubMed ID: 37331161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 antibody dynamics and B-cell memory response over time in COVID-19 convalescent subjects.
    Achiron A; Gurevich M; Falb R; Dreyer-Alster S; Sonis P; Mandel M
    Clin Microbiol Infect; 2021 Sep; 27(9):1349.e1-1349.e6. PubMed ID: 33975009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Six-month immune responses to mRNA-1273 vaccine in combination antiretroviral therapy treated late presenter people with HIV according to previous SARS-CoV-2 infection.
    Augello M; Bono V; Rovito R; Tincati C; d'Arminio Monforte A; Marchetti G
    AIDS; 2023 Aug; 37(10):1503-1517. PubMed ID: 37199415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 Testing and Positivity Among Persons With and Without HIV in 6 US Cohorts.
    Park LS; McGinnis KA; Gordon KS; Justice AC; Leyden W; Silverberg MJ; Skarbinski J; Jefferson C; Horberg M; Certa J; Napravnik S; Edwards JK; Westreich D; Bastarache L; Gangireddy S; Benning L; D'Souza G; Williams C; Althoff KN;
    J Acquir Immune Defic Syndr; 2022 Jul; 90(3):249-255. PubMed ID: 35195574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 infections post-vaccination by HIV status in the United States.
    Coburn SB; Humes E; Lang R; Stewart C; Hogan BC; Gebo KA; Napravnik S; Edwards JK; Browne LE; Park LS; Justice AC; Gordon K; Horberg MA; Certa JM; Watson E; Jefferson CR; Silverberg M; Skarbinski J; Leyden WA; Williams CF; Althoff KN;
    medRxiv; 2021 Dec; ():. PubMed ID: 34909791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal Assessment of SARS-CoV-2-Specific T Cell Cytokine-Producing Responses for 1 Year Reveals Persistence of Multicytokine Proliferative Responses, with Greater Immunity Associated with Disease Severity.
    Lin J; Law R; Korosec CS; Zhou C; Koh WH; Ghaemi MS; Samaan P; Ooi HK; Matveev V; Yue F; Gingras AC; Estacio A; Buchholz M; Cheatley PL; Mohammadi A; Kaul R; Pavinski K; Mubareka S; McGeer AJ; Leis JA; Heffernan JM; Ostrowski M
    J Virol; 2022 Jul; 96(13):e0050922. PubMed ID: 35699447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Course of Humoral and Cellular Immune Responses in Outpatients After SARS-CoV-2 Infection.
    Schiffner J; Backhaus I; Rimmele J; Schulz S; Möhlenkamp T; Klemens JM; Zapf D; Solbach W; Mischnik A
    Front Public Health; 2021; 9():732787. PubMed ID: 34646805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive concerns are a risk factor for mortality in people with HIV and coronavirus disease 2019.
    Wilcox DR; Rudmann EA; Ye E; Noori A; Magdamo C; Jain A; Alabsi H; Foy B; Triant VA; Robbins GK; Westover MB; Das S; Mukerji SS
    AIDS; 2023 Aug; 37(10):1565-1571. PubMed ID: 37195278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Analysis of Primary and Monovalent Booster SARS-CoV-2 Vaccination Coverage in Adults with and without HIV in Catalonia, Spain.
    Nomah DK; Reyes-Urueña J; Alonso L; Díaz Y; Moreno-Fornés S; Aceiton J; Bruguera A; Martín-Iguacel R; Imaz A; Gutierrez MDM; Román RW; Suanzes P; Ambrosioni J; Casabona J; Miro JM; Llibre JM; The Piscis Study Group
    Vaccines (Basel); 2023 Dec; 12(1):. PubMed ID: 38250857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6-8 months after the infection.
    Sherina N; Piralla A; Du L; Wan H; Kumagai-Braesch M; Andréll J; Braesch-Andersen S; Cassaniti I; Percivalle E; Sarasini A; Bergami F; Di Martino R; Colaneri M; Vecchia M; Sambo M; Zuccaro V; Bruno R; Sachs M; Oggionni T; Meloni F; Abolhassani H; Bertoglio F; Schubert M; Byrne-Steele M; Han J; Hust M; Xue Y; Hammarström L; Baldanti F; Marcotte H; Pan-Hammarström Q
    Med; 2021 Mar; 2(3):281-295.e4. PubMed ID: 33589885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.